TSE: 4565 - Sosei Group Corporation

Rentabilidade por seis meses: -37.64%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Sosei Group Corporation


Sobre a empresa Sosei Group Corporation

Sosei Group Corporation разрабатывает биофармацевтические продукты по всему миру. Его продаваемые продукты включают Ultibro/Breezhaler и Seebri/Breezhaler для лечения хронической обструктивной болезни легких; Enerzair для лечения астмы; и ORAVI, орофарингеальный кандидоз.

mais detalhes
Ассортимент продукции компании состоит из агониста GPR35 для лечения воспалительных заболеваний кишечника и желудочно-кишечного тракта, который находится на доклинической стадии; HTL0016878 для шизофрении и других нервно-психических расстройств; PF-07081532 при сахарном диабете 2 типа и ожирении; PF-07054894 при воспалительных заболеваниях кишечника; и PF-07258669 для анорексии. Корпорация Sosei Group имеет стратегическое сотрудничество с AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca и Takeda. Компания была зарегистрирована в 1990 году и имеет штаб-квартиру в Токио, Япония.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

Див.доход ао 0.3433
Дивиденд ао 2.5
Сайт https://soseiheptares.com
Цена ао 883
Alteração de preço por dia: -1.13% (883)
Alteração de preço por semana: +3.31% (845)
Alteração de preço por mês: -13.05% (1004)
Alteração de preço em 3 meses: -23.42% (1140)
Mudança de preço em seis meses: -37.64% (1400)
Mudança de preço por ano: -39.83% (1451)
Mudança de preço desde o início do ano: -16.7% (1048)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 8.88 1
P/BV 1.7 8
P/E 442.87 1
EV/EBITDA -21.01 0
Total: 3.88

Eficiência

Nome Significado Nota
ROA, % -4.58 0
ROE, % -10.77 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0.5 5
Total: 0.96

Obrigação

Nome Significado Nota
Debt/EBITDA -10.63 10
Total: 8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 344.81 10
Rentabilidade Ebitda, % -326.47 0
Rentabilidade EPS, % 11.19 2
Total: 3.2
Mais detalhes

Instituições Volume Compartilhar, %
Smallcap World Fund 1841200 2.06
Vanguard International Stock Index-Total Intl Stock Indx 997900 1.12
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 604000 0.68
iShares Core MSCI EAFE ETF 441300 0.49
iShares MSCI EAFE Small Cap ETF 284100 0.32
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 278200 0.31
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 149344 0.17
iShares Core MSCI Total International Stock ETF 129600 0.14
Vanguard International Stock Index-Pacific Stock Index 89400 0.1
iShares Core MSCI International Developed Markets ETF 62100 0.07

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
SPDR S&P International Small Cap ETF 0.04703 8.94 3.10348
Schwab International Small-Cap Equity ETF 0.0321 10.07 3.20638
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Direxion Daily Japan Bull 3x Shares 0.01875 6.34 2.48436
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.00644 5.17 3.85434
SPDR Portfolio Developed World ex-US ETF 0.00296 5.29 3.28401
SPDR Portfolio MSCI Global Stock Market ETF 0.00042 17.99 2.19607
Vanguard ESG International Stock ETF 0 6.39 3.07501



Supervisor Cargo Pagamento Ano de nascimento
Mr. Shinichi Tamura Founder & Chairman of the Board 233M 1949 (76 anos)
Mr. Hironoshin Nomura Executive Officer, Executive VP & CFO N/A 1983 (42 ano)
Mr. Kieran Johnson F.C.A. Executive Officer, Executive VP & Chief Accounting Officer N/A 1969 (56 anos)
Dr. Miles Congreve Chief Scientific Officer N/A
Mr. Kazuhiko Yoshizumi Executive Officer, Executive VP & Chief Compliance Officer N/A 1954 (71 ano)
Shinichiro Nishishita VP of Investor Relations & Head of Regulatory Disclosures N/A
Stacey Southall Associate Director & Head of Biophysics N/A
Ms. Candelle Chong Executive Officer, Executive VP & Chief of Staff N/A 1989 (36 anos)
Mr. Christopher Cargill Representative Executive Officer, President, CEO & Director 200M 1984 (41 ano)
Mr. Toshihiro Maeda Chief Operating Officer N/A

Endereço: Japan, Tokyo -, PMO Hanzomon - abrir no Google Maps, abrir mapas Yandex
Site: https://soseiheptares.com